IGC Receives No objection letter from Health Canada JAN 4. 3023 - IGC Pharma, INC.

Press

Releases

January 4, 2023

IGC Receives No objection letter from Health Canada JAN 4. 3023

Related Posts

IGC Pharma Expands AI-Powered Drug Discovery In-Silico Pipeline

November 3, 2025

IGC Pharma Advances to Semi-Finals in the Alzheimer’s Insights AI Prize with “AHA: Agentic Harmonization Assistant”

October 22, 2025

IGC Pharma Expands Phase 2 CALMA Clinical Trial to University of South Florida’s Department of Psychiatry and Behavioral Neurosciences

October 14, 2025

CEO Update

IGC Pharma Expands AI-Powered Drug Discovery In-Silico Pipeline

November 3, 2025

IGC Pharma Advances to Semi-Finals in the Alzheimer’s Insights AI Prize with “AHA: Agentic Harmonization Assistant”

October 22, 2025